Anavex Life Sciences Corp (AVXL)

[Investor2014]

So we now have (all) four theories presented:

1) Cunning plan by the FDA to once and for all convince the public and science that amyloid plaque clearing is not the answer to halt or reverse AD - all perhaps even ESPECIALLY for the benefit of Anavex

2) FDA were just desperate and under pressure to approve something new with a glimmer of hope for AD

3) Although aduhelm might be crap its approval is great for better candidates to clear a low bar and charge a good price

4) Big hurdle to unseat Biogen and the amyloid crowd, bad news for Anavex

Think all we can do is wait and see if the Anavex P2b/3 AD trial data comes out with a trump card or joker. If the former let's hope and expect the process and system works without having to dodge too many cabal bullets.